BeOne
BeOne Medicines
ONC pharma USA
Quick answer
BeOne is a pharma company (ONC) headquartered in BASEL, USA with 24 tracked pipeline programs.
Pipeline (24)
project
BGB-16673
CLL
1 trials projectBGB-16673
Chronic Lymphocytic Leukemia
2 trials projectBGB-43395
HR+/HER2- Breast Cancer
1 trials projectPamiparib capsule
Ovarian Cancer
1 trials projectSonrotoclax
Mantle Cell Lymphoma
1 trials projectSonrotoclax
Chronic Lymphocytic Leukemia
4 trials projectSonrotoclax
CLL
1 trials projectSubcutaneous Tislelizumab
Metastatic Gastric Adenocarcinoma
1 trials projectTislelizumab
Advanced Malignancies
1 trials projectTislelizumab
Classical Hodgkin Lymphoma
1 trials projectTislelizumab
Urothelial Carcinoma
1 trials projectTislelizumab
Esophageal Squamous Cell Carcinoma (ESCC)
1 trials projectTislelizumab
Non Small Cell Lung Cancer
4 trials projectZanidatamab
Gastric Neoplasms
1 trials projectZanubrutinib
Chronic Lymphocytic Leukemia
2 trials projectZanubrutinib
Primary Membranous Nephropathy
1 trials projectZanubrutinib
B-cell Malignancies
1 trials projectZanubrutinib
Relapsed/Refractory Follicular Lymphoma
1 trials projectzanubrutinib
Mantle Cell Lymphoma; Non-Hodgkin Lymphoma
1 trials projectAtezolizumab
Advanced Liver Cancers
1 trials projectBGB-10188
Chronic Lymphocytic Leukemia
1 trials projectBGB-11417
Leukemia
1 trials projectBGB-11417
Acute Myeloid Leukemia
1 trials projectBGB-16673
B-cell Malignancy
3 trials